To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CHTF18TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
180 supporting clones for gene CHTF18 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB125569 thymus .a 1 to 580 2 to 581   tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
BF182688 large cell carcinoma, lung .a 20 to 744 1 to 714   available from MGC,   713/943
(75 %)
74 diff
(92.2 %id)
BC006437 Lung, large cell carcinoma .a 22 to 3169 1 to 3148 exact tiling clone, available from MGC, AAA   3148/3148
(100 %)
1 diff
(100.0 %id)
BU540454 large cell carcinoma, lung .a 23 to 675 1 to 660       660/1015
(65 %)
16 diff
(98.5 %id)
AL524240 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 37 to 1038 1 to 1003       1003/1092
(91 %)
8 diff
(99.3 %id)
NM_022092.2   .b 1 to 3093 4 to 3096 exact RefSeq,   3096/3096
(100 %)
6 diff
(99.9 %id)
DC410609 thymus .b 1 to 312 4 to 314       314/314
(100 %)
1 diff
(99.7 %id)
BM150350 leukopheresis .b 1 to 469 3 to 469       469/471
(99 %)
16 diff
(96.7 %id)
DC307213 cerebellum .b 1 to 497 2 to 499       499/506
(98 %)
3 diff
(99.5 %id)
DC307955 cerebellum .b 1 to 551 2 to 552   tiling clone,   552/552
(100 %)
1 diff
(99.9 %id)
DC317627 amygdala .b 1 to 480 2 to 482       482/482
(100 %)
2 diff
(99.6 %id)
DC318603 amygdala .b 1 to 497 2 to 498       498/505
(98 %)
3 diff
(99.5 %id)
DC324432 brain .b 1 to 587 2 to 589       589/589
(100 %)
4 diff
(99.4 %id)
DC332602 hippocampus .b 1 to 540 2 to 543       543/543
(100 %)
3 diff
(99.5 %id)
DC332811 hippocampus .b 1 to 497 2 to 500       500/507
(98 %)
4 diff
(99.3 %id)
DC335747 hippocampus .b 1 to 569 2 to 571       571/571
(100 %)
2 diff
(99.7 %id)
DB470370 hippocampus .b 1 to 439 2 to 440       440/440
(100 %)
2 diff
(99.6 %id)
BF308850 muscle, rhabdomyosarcoma .b 1 to 661 2 to 661       661/819
(80 %)
19 diff
(97.7 %id)
BF306837 muscle, rhabdomyosarcoma .b 1 to 742 2 to 722       722/883
(81 %)
32 diff
(96.4 %id)
BG825945 muscle, rhabdomyosarcoma .b 1 to 498 2 to 516   tiling clone,   516/1111
(46 %)
35 diff
(96.9 %id)
DC372175   .b 1 to 576 2 to 579       579/579
(100 %)
3 diff
(99.5 %id)
DC382167 placenta .b 1 to 545 2 to 547       547/547
(100 %)
2 diff
(99.7 %id)
DC403881 testis .b 1 to 559 2 to 561       561/561
(100 %)
2 diff
(99.7 %id)
BU845239 ovary, teratocarcinoma, cell line .b 12 to 667 29 to 690       662/1035
(63 %)
29 diff
(97.2 %id)
BF347314 anaplastic oligodendroglioma with 1p/19qloss, brain .b 14 to 666 1 to 663       663/696
(95 %)
38 diff
(94.6 %id)
BU845747 ovary, teratocarcinoma, cell line .b 18 to 803 1 to 791       789/965
(81 %)
16 diff
(98.4 %id)
BC018184 Brain, anaplastic oligodendroglioma with1p/19q loss .b 23 to 3085 1 to 3063 exact tiling clone, available from MGC, AAA   3063/3063
(100 %)
6 diff
(99.9 %id)
BX447012 neuroblastoma .b 23 to 887 1 to 865       865/869
(99 %)
5 diff
(99.5 %id)
DA247225 brain .b 28 to 622 2 to 596   capped   595/595
(100 %)
2 diff
(99.7 %id)
BG481033 choriocarcinoma, placenta .b 30 to 746 1 to 720       720/720
(100 %)
12 diff
(98.4 %id)
DB157694 thymus .b 30 to 420 2 to 392   capped   391/397
(98 %)
3 diff
(99.3 %id)
BC006278 Placenta, choriocarcinoma .b 31 to 3085 1 to 3055 Q82P K244R P928L tiling clone, available from MGC, AAA   3055/3055
(100 %)
7 diff
(99.8 %id)
DB451497 testis .b 38 to 524 1 to 487       487/487
(100 %)
1 diff
(99.8 %id)
CN361518 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 49 to 423 1 to 375       375/375
(100 %)
1 diff
(99.8 %id)
BE901267 choriocarcinoma, placenta .b 50 to 810 1 to 755       755/940
(80 %)
19 diff
(98.0 %id)
BE902046 choriocarcinoma, placenta .b 51 to 766 1 to 706       706/890
(79 %)
24 diff
(97.4 %id)
DN999685   .b 52 to 564 8 to 520       513/523
(98 %)
8 diff
(98.5 %id)
BI766695 pooled lung and spleen .b 54 to 812 1 to 771       769/775
(99 %)
30 diff
(96.2 %id)
TI_1948226739   .b 58 to 667 134 to 743       610/1464
(41 %)
14 diff
(99.1 %id)
TI_1948239198   .b 58 to 953 125 to 1008       884/1291
(68 %)
37 diff
(97.2 %id)
TI_1948239199   .b 58 to 812 137 to 893       757/1169
(64 %)
13 diff
(98.9 %id)
TI_1948239236   .b 58 to 953 128 to 1026   AAA   899/1325
(67 %)
26 diff
(98.1 %id)
TI_1948239237   .b 58 to 812 133 to 890       758/1115
(67 %)
20 diff
(98.3 %id)
TI_1948239487   .b 58 to 954 125 to 1022       898/1345
(66 %)
22 diff
(98.4 %id)
TI_1948239488   .b 58 to 812 133 to 888       756/1120
(67 %)
9 diff
(99.2 %id)
TI_1948239770   .b 58 to 1099 123 to 1164       1042/1374
(75 %)
36 diff
(97.4 %id)
TI_1948239771   .b 58 to 812 132 to 885       754/1153
(65 %)
13 diff
(98.9 %id)
EL733155 mixed .b 61 to 711 1 to 649       649/650
(99 %)
10 diff
(98.5 %id)
EL735938 mixed .b 61 to 715 1 to 651       651/651
(100 %)
11 diff
(98.4 %id)
CN361517 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 75 to 652 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BI196074 brain, neuroblastoma .b 242 to 912 1 to 671       671/673
(99 %)
11 diff
(98.4 %id)
BE262702 brain, neuroblastoma .b 259 to 954 54 to 748       697/1059
(65 %)
45 diff
(95.8 %id)
BG168881 hypernephroma, cell line, Kidney .b 350 to 1127 1 to 777       772/925
(83 %)
30 diff
(96.8 %id)
BQ645867 hepatocellular carcinoma, cell line, Liver .b 605 to 1170 50 to 620       571/1262
(45 %)
22 diff
(98.3 %id)
BQ650965 hepatocellular carcinoma, cell line, Liver .b 607 to 1392 1 to 793       793/975
(81 %)
22 diff
(97.8 %id)
BQ646300 hepatocellular carcinoma, cell line, Liver .b 609 to 1387 1 to 788       788/911
(86 %)
21 diff
(97.7 %id)
BQ651106 hepatocellular carcinoma, cell line, Liver .b 609 to 1236 14 to 644       631/1049
(60 %)
19 diff
(98.2 %id)
BQ646373 hepatocellular carcinoma, cell line, Liver .b 609 to 1165 14 to 571       558/1036
(53 %)
11 diff
(99.0 %id)
TI_59385938   .b 609 to 1262 83 to 763       677/1142
(59 %)
52 diff
(95.5 %id)
BQ650789 hepatocellular carcinoma, cell line, Liver .b 610 to 1394 1 to 788       788/918
(85 %)
32 diff
(96.6 %id)
BQ645686 hepatocellular carcinoma, cell line, Liver .b 626 to 1383 1 to 761       761/870
(87 %)
11 diff
(98.8 %id)
BQ648925 hepatocellular carcinoma, cell line, Liver .b 626 to 1266 1 to 651       651/885
(73 %)
12 diff
(98.7 %id)
BM005987 hepatocellular carcinoma, cell line, Liver .b 628 to 1262 1 to 662       607/1041
(58 %)
46 diff
(95.6 %id)
BU553656 ovary, teratocarcinoma, cell line .b 717 to 1624 1 to 918       918/918
(100 %)
25 diff
(97.3 %id)
BM806765 lymph, lymphoma, cell line .b 789 to 1631 1 to 844       844/1041
(81 %)
8 diff
(99.3 %id)
CX759008 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1012 to 1692 1 to 690       690/878
(78 %)
18 diff
(98.0 %id)
BM906352 ovary (pool of 3) .b 1066 to 1540 12 to 492       481/1091
(44 %)
14 diff
(98.8 %id)
CK906217 Islets of Langerhans, Pancreas .b 1098 to 1674 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BM127632 Islets of Langerhans, Pancreas .b 1114 to 1675 1 to 562       562/562
(100 %)
0 diff
(100 %id)
DN602089 human embryonic stem cells .b 1118 to 1731 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BE242499 leukopheresis .b 1260 to 1604 345 to 1       345/345
(100 %)
9 diff
(97.4 %id)
BI457170 epithelioid carcinoma cell line, Pancreas .b 1312 to 2236 1 to 924       924/956
(96 %)
58 diff
(94.0 %id)
TI_45133410   .b 1313 to 2236 64 to 986       923/955
(96 %)
57 diff
(94.1 %id)
BQ962210 epithelioid carcinoma cell line, Pancreas .b 1314 to 2170 1 to 869       869/912
(95 %)
18 diff
(98.1 %id)
CN361515 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1318 to 1663 1 to 345       345/345
(100 %)
1 diff
(99.8 %id)
BX371387 Neuroblastoma Cot 25-normalized .b 1321 to 2215 905 to 10       896/905
(99 %)
12 diff
(98.7 %id)
BU509771 leiomyosarcoma, uterus .b 1366 to 2170 1 to 822       820/903
(90 %)
27 diff
(97.1 %id)
AL516520 brain, neuroblastoma, neuroblastoma cells .b 1434 to 2282 1 to 852       852/947
(89 %)
13 diff
(98.7 %id)
DA933585 Spleen .b 1451 to 2010 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BM793661 Ascites, stomach .b 1539 to 1990 11 to 463       453/463
(97 %)
10 diff
(97.9 %id)
BY795945 eye .b 1540 to 2123 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
TI_57201416   .b 1599 to 2373 61 to 851       791/853
(92 %)
36 diff
(95.8 %id)
BI823171 pooled brain, lung, testis .b 1600 to 2373 1 to 790       790/792
(99 %)
31 diff
(96.1 %id)
BE795677 lung, small cell carcinoma .b 1793 to 2622 1 to 821       821/1042
(78 %)
17 diff
(98.4 %id)
BE797877 lung, small cell carcinoma .b 1804 to 2663 1 to 860       860/958
(89 %)
31 diff
(96.8 %id)
AA352175   .b 1933 to 2200 1 to 268       268/268
(100 %)
0 diff
(100 %id)
AL562324 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 2008 to 3056 1043 to 7       1037/1143
(90 %)
24 diff
(98.0 %id)
TI_1948239489   .b 2008 to 2984 1102 to 130       973/1379
(70 %)
19 diff
(98.7 %id)
TI_1948239773   .b 2008 to 2984 1101 to 130       972/1425
(68 %)
37 diff
(97.5 %id)
CN361508 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2020 to 2547 1 to 528       528/528
(100 %)
1 diff
(99.9 %id)
TI_1948239200   .b 2042 to 2984 1061 to 128       934/1355
(68 %)
39 diff
(97.2 %id)
BF093805 uterus .b 2047 to 2551 1 to 513       460/516
(89 %)
31 diff
(94.0 %id)
BE888887 leiomyosarcoma, uterus .b 2090 to 2733 1 to 642       642/644
(99 %)
10 diff
(98.5 %id)
TI_1948239238   .b 2092 to 2984 1027 to 126       902/1471
(61 %)
36 diff
(97.6 %id)
TI_1948239490   .b 2093 to 2984 1011 to 129       883/1343
(65 %)
17 diff
(98.8 %id)
BE898071 melanotic melanoma, skin .b 2099 to 2796 1 to 700       700/884
(79 %)
11 diff
(98.8 %id)
AW904596 nervous_normal .b 2104 to 2261 162 to 5       158/173
(91 %)
4 diff
(97.7 %id)
TI_1948239201   .b 2105 to 2984 1009 to 131       879/1331
(66 %)
19 diff
(98.6 %id)
TI_1948239239   .b 2147 to 2984 968 to 131       838/1337
(62 %)
4 diff
(99.8 %id)
TI_1948239772   .b 2196 to 2984 915 to 128       788/1431
(55 %)
10 diff
(99.4 %id)
BM703773 eye, human retina .b 2261 to 2703 1 to 443       443/443
(100 %)
1 diff
(99.8 %id)
BU159091 embryonal carcinoma, cell line, testis .b 2273 to 2805 1 to 542   AAA   542/923
(58 %)
16 diff
(98.3 %id)
AA478378 ovarian tumor, ovary .b 2285 to 2677 1 to 385       385/386
(99 %)
9 diff
(97.7 %id)
BU625412 cell lines, Enchondroma .b 2364 to 3085 740 to 19   AAA   722/725
(99 %)
2 diff
(99.8 %id)
BU633872 cell lines, Chondrosarcoma .b 2368 to 3085 736 to 19   AAA   718/718
(100 %)
0 diff
(100 %id)
AL516519 brain, neuroblastoma, neuroblastoma cells .b 2378 to 3046 666 to 1       666/971
(68 %)
24 diff
(97.6 %id)
BM832965 stomach .b 2383 to 2907 7 to 530       524/530
(98 %)
13 diff
(97.6 %id)
TI_151712753   .b 2392 to 3085 816 to 125   AAA   692/959
(72 %)
24 diff
(97.5 %id)
BM674122 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2397 to 3085 707 to 19   AAA   689/689
(100 %)
1 diff
(99.9 %id)
AW973666   .b 2440 to 3081 641 to 1     Submitted on the opposite strand 641/694
(92 %)
3 diff
(99.6 %id)
ES311090 scalp interfollicular dermis, skin .b 2445 to 3087 1 to 642       642/645
(99 %)
12 diff
(98.2 %id)
BU616468 Bone, Subchondral Bone .b 2470 to 3085 634 to 19   AAA   616/616
(100 %)
1 diff
(99.9 %id)
BQ773121 Chondrosarcoma Cell line .b 2495 to 3085 609 to 19   AAA   591/591
(100 %)
2 diff
(99.7 %id)
TI_151703686   .b 2512 to 3085 656 to 81       576/1348
(42 %)
14 diff
(99.0 %id)
BM127327 Islets of Langerhans, Pancreas .b 2518 to 3087 572 to 2       571/572
(99 %)
0 diff
(100 %id)
CK906216 Islets of Langerhans, Pancreas .b 2524 to 3087 565 to 2       564/565
(99 %)
0 diff
(100 %id)
BF513105   .b 2553 to 3085 550 to 18   AAA   533/533
(100 %)
0 diff
(100 %id)
AI831961 B-cell, chronic lymphotic leukemia .b 2596 to 3087 496 to 5       492/496
(99 %)
0 diff
(100 %id)
C21278   .b 2601 to 2716 1 to 116       116/116
(100 %)
3 diff
(97.5 %id)
BX117345 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 2616 to 3082 481 to 15   AAA   467/467
(100 %)
1 diff
(99.8 %id)
DB516963 testis .b 2616 to 3078 1 to 463     Submitted on the opposite strand 463/463
(100 %)
1 diff
(99.8 %id)
AI650845 pooled germ cell tumors .b 2623 to 3087 471 to 7       465/471
(98 %)
0 diff
(100 %id)
BE300859 choriocarcinoma, placenta .b 2623 to 3087 469 to 5       465/469
(99 %)
1 diff
(99.8 %id)
AW196692 pooled germ cell tumors .b 2629 to 3087 465 to 7       459/465
(98 %)
0 diff
(100 %id)
BQ073027 leukocyte .b 2645 to 3085 1 to 441       441/474
(93 %)
2 diff
(99.6 %id)
AI824849 pooled germ cell tumors .b 2659 to 3087 434 to 6       429/440
(97 %)
0 diff
(100 %id)
AI620989 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2684 to 3085 412 to 11   AAA   402/402
(100 %)
0 diff
(100 %id)
AI355547 ovary, tumor, 5 pooled (see description) .b 2696 to 3082 424 to 37   AAA   388/388
(100 %)
18 diff
(95.4 %id)
AW236312 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .b 2696 to 3087 392 to 1       392/392
(100 %)
0 diff
(100 %id)
AI918000 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 2698 to 3082 386 to 3       384/408
(94 %)
1 diff
(99.8 %id)
AW662226 2 pooled high-grade transitional celltumors, genitourinary tract .b 2713 to 3089 377 to 1       377/377
(100 %)
2 diff
(99.5 %id)
AA610722 thyroid .b 2742 to 3087 347 to 3       345/347
(99 %)
1 diff
(99.8 %id)
AI276362 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 2757 to 3085 347 to 16   AAA   332/375
(88 %)
6 diff
(98.4 %id)
AW149595 brain, medulloblastoma .b 2778 to 3087 317 to 7       311/317
(98 %)
0 diff
(100 %id)
AW467884 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .b 2791 to 3087 294 to 1       294/310
(94 %)
3 diff
(99.1 %id)
AI382635 B-cell, chronic lymphotic leukemia .b 2848 to 3087 244 to 5       240/250
(96 %)
0 diff
(100 %id)
AI689357 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2848 to 3082 254 to 20   AAA   235/246
(95 %)
3 diff
(98.8 %id)
D80414 brain .b 2885 to 3085 1 to 201       201/201
(100 %)
2 diff
(99.1 %id)
D80923 brain .b 2885 to 3085 1 to 201       201/201
(100 %)
3 diff
(98.6 %id)
AI341250 pooled germ cell tumors .b 2903 to 3086 184 to 1       184/184
(100 %)
0 diff
(100 %id)
AA992619   .b 2958 to 3079 125 to 3       123/129
(95 %)
0 diff
(100 %id)
AA558991 breast .b 2959 to 3081 123 to 1       123/123
(100 %)
0 diff
(100 %id)
AK024476 Spleen .c 1 to 4494 1 to 4494 exact tiling clone, available from FLJ,   4494/4494
(100 %)
1 diff
(100.0 %id)
CN361509 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 2462 to 3064 1 to 603       603/603
(100 %)
3 diff
(99.6 %id)
D61532   .c 2646 to 3082 1 to 436       436/436
(100 %)
2 diff
(99.6 %id)
AK128869 uterus .d 1 to 4085 4 to 4088 exact tiling clone, available from FLJ,   4088/4088
(100 %)
2 diff
(100.0 %id)
DB279052 uterus .d 1 to 549 4 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
CN361516 embryonic stem cells, cell lines H1, H7, andH9 .d 498 to 741 37 to 280       244/280
(87 %)
7 diff
(97.5 %id)
CN361507 embryonic stem cells, cell lines H1, H7, andH9 .d 1100 to 1671 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
AW631061 2 pooled high-grade transitional celltumors, genitourinary tract .d 1217 to 1568 1 to 352       352/352
(100 %)
0 diff
(100 %id)
DB163691 thymus .d 1458 to 2041 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
BF902581 marrow .d 1460 to 1634 1 to 176       176/176
(100 %)
3 diff
(98.3 %id)
DA440318 tongue, tumor tissue .d 1690 to 2262 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
CN361510 embryonic stem cells, cell lines H1, H7, andH9 .d 1705 to 2113 1 to 409       409/409
(100 %)
0 diff
(100 %id)
DB352362 uterus .d 3643 to 4077 443 to 9       435/443
(98 %)
0 diff
(100 %id)
AK309804 brain .e 1 to 1801 1 to 1801 K245R tiling clone,   1801/1801
(100 %)
3 diff
(99.9 %id)
DC375996 brain .e 1 to 564 1 to 565       565/565
(100 %)
2 diff
(99.7 %id)
BG480239 choriocarcinoma, placenta .e 1496 to 2256 1 to 762   tiling clone,   762/809
(94 %)
23 diff
(97.2 %id)
BE279389 choriocarcinoma, placenta .e 1516 to 2096 1 to 588   tiling clone,   586/588
(99 %)
9 diff
(98.5 %id)
BQ231004 epithelioid carcinoma, Pancreas .e 1971 to 2853 1 to 889   tiling clone,   889/898
(98 %)
16 diff
(98.3 %id)
CN361511 embryonic stem cells, cell lines H1, H7, andH9 .f 1 to 470 2 to 471   tiling clone,   471/471
(100 %)
2 diff
(99.6 %id)
CN361512 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 50 to 433 1 to 384       384/384
(100 %)
4 diff
(99.0 %id)
BE780529 eye, retinoblastoma .f 443 to 1171 1 to 735   tiling clone,   735/1029
(71 %)
22 diff
(97.9 %id)
BE313266 brain, neuroblastoma .f 809 to 1480 1 to 674   tiling clone,   674/734
(91 %)
20 diff
(97.3 %id)
BE314193 brain, neuroblastoma .f 809 to 1343 1 to 535   tiling clone,   535/535
(100 %)
2 diff
(99.7 %id)
AK293846 cerebellum .g 1 to 1109 2 to 1110 exact tiling clone,   1110/1110
(100 %)
2 diff
(99.9 %id)
DR762517 embryonic stem .g 1003 to 1703 1 to 700   tiling clone,   700/700
(100 %)
1 diff
(99.9 %id)
CN361513 embryonic stem cells, cell lines H1, H7, andH9 .h 1 to 603 13 to 615   tiling clone,   603/615
(98 %)
6 diff
(99.1 %id)
CN361514 embryonic stem cells, DMSO-treated H9 cellline .h 346 to 984 1 to 639   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 639/647
(98 %)
2 diff
(99.7 %id)
CA421425 Chondrosarcoma Grade II, Left Pelvis .i 1 to 671 687 to 19 A4L F5L V7L C8R G9L ... tiling clone, AAA   669/669
(100 %)
3 diff
(99.6 %id)
BM715777 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 1 to 691 1 to 692 exact tiling clone,   692/692
(100 %)
2 diff
(99.8 %id)
BM701214 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 41 to 368 1 to 328       328/328
(100 %)
0 diff
(100 %id)
BF434726 fibrotheoma, ovary .k 1 to 522 1 to 522   tiling clone, Submitted on the opposite strand 522/522
(100 %)
1 diff
(99.9 %id)
BQ367862 placenta_normal .k 373 to 941 1 to 576 exact tiling clone,   576/577
(99 %)
19 diff
(96.8 %id)
DB538485 hippocampus Gene CHTF18, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BF745999 breast Gene CHTF18, variant not shown         This clone was ignored    
DB305658 brain Gene CHTF18, variant not shown         Submitted on the opposite strand    
AI401116 B-cell, chronic lymphotic leukemia Gene CHTF18, variant not shown         This clone was ignored    
AI916173 colon, colon tumor, RER+ Gene CHTF18, variant not shown         Suspected internal deletion, this clone was ignored    
BG761379 melanotic melanoma, high MDR (cell line), skin Gene CHTF18, variant not shown         Suspected internal deletion, this clone was ignored    
TI_57181277   Gene CHTF18, variant not shown         This clone was ignored    
DB089752 testis Gene CHTF18, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB341330 testis Gene CHTF18, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI